HeartBeam, Inc.

Nasdaq BEATW · Santa Clara, CA

Works in Cardiovascular

HeartBeam, Inc. is a clinical trial sponsor based in Santa Clara, CA, listed as Nasdaq BEATW. It has 2 active clinical trials with 720 planned participants, in Cardiovascular. Since 2021 it has completed 1 trial and stopped 0 early. Its FDA record on file shows 1 inspection.

Trial track record · since 2021

2Active trials720 planned participants
1Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

FDA record

1InspectionLatest 2026-09-16: Voluntary action indicated
0Warning lettersNone on file
0RecallsNone on file

Recent FDA actions

Financials · Nasdaq BEATW

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 2 active trials

StageTrialStatus

Questions about HeartBeam, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-20.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with HeartBeam, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.